Canada-based laboratory software company GenoLogics secured $8m of series D funding on Thursday in a round led by biotechnology analysis firm Illumina.

GenoLogics raised $5m in series C financing, in February 2009, from venture capital firm OVP Venture Partners, Yaletown Venture Partners and Growthworks Capital, all of which also invested in GenoLogics’ 2006 series B round. OVP originally provided $3.1m in series A financing in February 2005.

The funding follows Genologics’ signing of a global co-selling agreement with Illumina…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?